Keywords: Rheumatoid arthritis, Biologicals, Patients views, Amgen, Pfizer, Enbrel, Methotrexate, Decision Resources

Enbrel gets highest rating among RA biologicals by surveyed US patients

Article | 02 September 2012

Print This

For surveyed rheumatoid arthritis (RA) patients on biologic therapy, the benefits outweigh the risks for all of the available biologic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in